Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

Abstract Background Although immune checkpoint inhibitor (ICI) is regarded as a breakthrough in cancer therapy, only a limited fraction of patients benefit from it. Cancer stemness can be the potential culprit in ICI resistance, but direct clinical evidence is lacking. Methods Publicly available scR...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Zhen Zhang, Zi-Xian Wang, Yan-Xing Chen, Hao-Xiang Wu, Ling Yin, Qi Zhao, Hui-Yan Luo, Zhao-Lei Zeng, Miao-Zhen Qiu, Rui-Hua Xu
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMC 2022-04-01
Reeks:Genome Medicine
Onderwerpen:
Big data analysis
Single-cell sequencing
Immune checkpoint therapy
Stemness
Pan-cancer
Online toegang:https://doi.org/10.1186/s13073-022-01050-w
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items